Insiders · VRCA

VRCA insider transactions

Verrica Pharmaceuticals Inc. (VRCA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for VRCA

• 121d
  Amendment: SEC Form 3 filed by new insider Bkb Growth Investments, Llc

  3/A - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 128d
  New insider Bkb Growth Investments, Llc claimed ownership of 3,348,372 shares (SEC Form 3)

  3 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 155d
  Interim CFO Kirby John J. was granted 10,000 shares, increasing direct ownership by 112% to 18,962 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 155d
  New insider Caligan Partners Lp claimed ownership of 923,910 shares (SEC Form 3)

  3 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 155d
  SEC Form 3 filed by new insider Frantzreb Charles

  3 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 189d
  CMO Rosenberg Noah L. bought $10,000 worth of shares (2,357 units at $4.24) (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 189d
  Director Manning Paul B bought $17,505,157 worth of shares (4,126,142 units at $4.24) (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 189d
  Chief Operating Officer Zawitz David bought $42,425 worth of shares (10,000 units at $4.24), increasing direct ownership by 91% to 21,000 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 189d
  CEO and President Rieger Jayson bought $400,114 worth of shares (94,311 units at $4.24), increasing direct ownership by 107% to 182,593 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 189d
  Interim CFO Kirby John J. bought $15,001 worth of shares (3,536 units at $4.24), increasing direct ownership by 65% to 8,962 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 359d
  SEC Form 4 filed by Director Nguyen Diem

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 359d
  SEC Form 4 filed by Director Corcoran Gavin

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 359d
  SEC Form 4 filed by Director Prygocki Mark A Sr

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 359d
  SEC Form 4 filed by Director Eichenfield Lawrence

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 427d
  SEC Form 4 filed by Director Corcoran Gavin

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 427d
  New insider Corcoran Gavin claimed ownership of 20 shares (SEC Form 3)

  3 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 434d
  SEC Form 4 filed by CMO Rosenberg Noah L.

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 434d
  SEC Form 3 filed by new insider Rosenberg Noah L.

  3 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 441d
  CHIEF LEGAL OFFICER Hayes Christopher G. sold $2,805 worth of shares (4,315 units at $0.65), decreasing direct ownership by 2% to 176,458 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 441d
  SEC Form 4 filed by CEO and President Rieger Jayson

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 482d
  Amendment: Chief Medical Officer Goldenberg Gary was granted 50,000 shares, increasing direct ownership by 71% to 120,110 units (SEC Form 4)

  4/A - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 482d
  Amendment: CHIEF LEGAL OFFICER Hayes Christopher G. was granted 150,000 shares, increasing direct ownership by 183% to 231,925 units (SEC Form 4)

  4/A - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 482d
  Amendment: PRESIDENT AND CEO White Ted was granted 150,000 shares, increasing direct ownership by 116% to 278,789 units (SEC Form 4)

  4/A - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 482d
  Amendment: CHIEF FINANCIAL OFFICER Kohler Terry was granted 125,000 shares (SEC Form 4)

  4/A - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 482d
  Amendment: CHIEF COMMERCIAL OFFICER Bonaccorso Joe was granted 125,000 shares, increasing direct ownership by 199% to 187,738 units (SEC Form 4)

  4/A - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 541d
  SEC Form 4 filed by Chief Operating Officer Zawitz David

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 541d
  New insider Zawitz David claimed ownership of 110,000 shares (SEC Form 3)

  3 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 554d
  Director Stalfort John A Iii bought 1,123,595 shares and received a gift of 50,000 shares, increasing direct ownership by 168% to 1,873,800 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 554d
  CEO and President Rieger Jayson bought 280,898 shares and received a gift of 50,000 shares, increasing direct ownership by 60% to 882,826 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 554d
  Director Manning Paul B bought 22,921,348 shares and gifted 450,000 shares (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 573d
  Interim CFO Kirby John J. was granted 54,267 shares (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 573d
  SEC Form 3 filed by new insider Kirby John J.

  3 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 573d
  SEC Form 4 filed by CEO and President Rieger Jayson

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 573d
  New insider Rieger Jayson claimed ownership of 558,983 shares (SEC Form 3)

  3 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 600d
  SEC Form 4 filed by CHIEF LEGAL OFFICER Hayes Christopher G.

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 618d
  Director Manning Paul B gifted 2,675,611 shares and received a gift of 2,675,611 shares (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 644d
  CHIEF LEGAL OFFICER Hayes Christopher G. sold $93,091 worth of shares (35,713 units at $2.61), decreasing direct ownership by 25% to 105,773 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 644d
  CHIEF FINANCIAL OFFICER Kohler Terry sold $77,473 worth of shares (29,719 units at $2.61), decreasing direct ownership by 40% to 44,697 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 644d
  CHIEF COMMERCIAL OFFICER Bonaccorso Joe sold $87,849 worth of shares (33,702 units at $2.61), decreasing direct ownership by 32% to 73,114 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 644d
  Chief Medical Officer Goldenberg Gary sold $35,161 worth of shares (13,489 units at $2.61), decreasing direct ownership by 13% to 94,261 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 644d
  PRESIDENT AND CEO White Ted sold $88,636 worth of shares (34,000 units at $2.61), decreasing direct ownership by 14% to 215,967 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 680d
  PRESIDENT AND CEO White Ted sold $230,306 worth of shares (32,623 units at $7.06), decreasing direct ownership by 12% to 249,967 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 680d
  CHIEF COMMERCIAL OFFICER Bonaccorso Joe sold $180,557 worth of shares (25,576 units at $7.06), decreasing direct ownership by 19% to 106,816 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 680d
  Chief Medical Officer Goldenberg Gary sold $130,653 worth of shares (18,507 units at $7.06), decreasing direct ownership by 15% to 107,750 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 680d
  CHIEF LEGAL OFFICER Hayes Christopher G. sold $153,477 worth of shares (21,740 units at $7.06), decreasing direct ownership by 13% to 141,486 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 726d
  SEC Form 4 filed by Nguyen Diem

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 726d
  SEC Form 4 filed by Eichenfield Lawrence

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 726d
  SEC Form 4 filed by Ballaron Craig

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 726d
  SEC Form 4 filed by Prygocki Mark A Sr

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 806d
  White Ted was granted 112,500 shares, increasing direct ownership by 66% to 282,590 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 806d
  Kohler Terry was granted 40,000 shares, increasing direct ownership by 116% to 74,416 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 806d
  Hayes Christopher G. was granted 40,000 shares, increasing direct ownership by 32% to 163,226 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 806d
  Goldenberg Gary was granted 40,000 shares, increasing direct ownership by 46% to 126,257 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 806d
  Bonaccorso Joe was granted 40,000 shares, increasing direct ownership by 43% to 132,392 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 887d
  Perceptive Advisors Llc bought $2,305,132 worth of shares (321,616 units at $7.17) (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 889d
  Perceptive Advisors Llc bought $3,256,191 worth of shares (504,652 units at $6.45) (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 896d
  Perceptive Advisors Llc bought $6,941,716 worth of shares (1,233,931 units at $5.63) (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 930d
  Bonaccorso Joe sold $96,689 worth of shares (32,846 units at $2.94), decreasing direct ownership by 26% to 92,392 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 930d
  Goldenberg Gary sold $26,061 worth of shares (8,853 units at $2.94), decreasing direct ownership by 9% to 86,257 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)
• 930d
  Kohler Terry sold $82,671 worth of shares (28,084 units at $2.94), decreasing direct ownership by 45% to 34,416 units (SEC Form 4)

  4 - Verrica Pharmaceuticals Inc. (0001660334) (Issuer)